{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:13:35Z","timestamp":1789402415632,"version":"build-2803163510"},"reference-count":64,"publisher":"Open Exploration Publishing","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/doi.org\/10.37349\/Open_Exploration_Crossmark_Policy"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI 145265"],"award-info":[{"award-number":["R01 AI 145265"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI 095227"],"award-info":[{"award-number":["U19 AI 095227"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI 111820"],"award-info":[{"award-number":["R01 AI 111820"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Explor Asthma Allergy"],"abstract":"<jats:p>Glucagon-like peptide-1 (GLP-1) is a hormone that regulates blood glucose levels and is produced by the enteroendocrine glands in the large and small intestines in response to the consumption of foods that contain carbohydrates, fats, and proteins. When GLP-1 is secreted, it acts on the pancreas to increase insulin production and secretion, while decreasing pancreatic glucagon secretion in order to lower serum glucose. However, GLP-1 also regulates metabolism through the gut-brain axis. While GLP-1 is primarily produced in the gut and released into the bloodstream, small quantities of it can also be synthesized in distinct areas of neurons located in the hindbrain. Recent studies have proposed that GLP-1 receptor (GLP-1R) agonists (GLP-1RAs) may protect against neuroinflammatory diseases. GLP-1RAs may also be a therapeutic target for asthma as animal models show that these drugs reduce allergen-induced airway inflammation, as the GLP-1R is expressed on lung epithelial and endothelial cells. There is a notable association between insulin resistance and the onset of asthma, particularly among obese people, with this association suggesting that metabolic dysfunction may play a role in asthma development. There is also evidence that there may be a link between asthma pathobiology and neuroinflammation, suggesting that GLP-1 and its analogs may regulate neuroinflammatory pathways that contribute to asthma pathogenesis. Interest is growing, though research remains limited, in how inflammation in the nervous system and lung might be linked. This review will explore how GLP-1R signaling could inhibit interdependent inflammation in both the lung and nervous system. This review will first focus on the inflammation that is known to exist in asthma, then pivot to the current state of neural regulation of asthma, and finally speculate on how GLP-1RA signaling could inhibit both neural and lung inflammation in asthma treatment.<\/jats:p>","DOI":"10.37349\/eaa.2025.100967","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T05:16:30Z","timestamp":1737004590000},"update-policy":"https:\/\/doi.org\/10.37349\/open_exploration_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The therapeutic potential of glucagon-like peptide-1 receptor analogs for neuroinflammation in the setting of asthma"],"prefix":"10.37349","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8083-693X","authenticated-orcid":false,"given":"Courtney","family":"Lehman","sequence":"first","affiliation":[{"name":"Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-7875","authenticated-orcid":false,"given":"Ray Stokes","family":"Peebles Jr","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; United States Department of Veterans Affairs, Nashville, TN 37215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21850","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Kanaya A, Yang M, Emala C, Mikami M. Chronic allergic lung inflammation negatively influences neurobehavioral outcomes in mice. J Neuroinflammation. 2022;19:210. [PMID: 36045388 PMCID: PMC9429782 DOI: 10.1186\/s12974-022-02575-y]","DOI":"10.1164\/ajrccm-conference.2022.205.1_meetingabstracts.a3759"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin SL, Globe G, et al. Asthma control in the United States, 2008-2010: indicators of poor asthma control. J Allergy Clin Immunol. 2014;133:1579\u201387. [PMID: 24331376 DOI: 10.1016\/j.jaci.2013.10.028]","DOI":"10.1016\/j.jaci.2013.10.028"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391:783\u2013800. [PMID: 29273246 DOI: 10.1016\/S0140-6736(17)33311-1]","DOI":"10.1016\/s0140-6736(17)33311-1"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Wu AY, Peebles RS. The GLP-1 receptor in airway inflammation in asthma: a promising novel target? Expert Rev Clin Immunol. 2021;17:1053\u20137. [PMID: 34425713 PMCID: PMC8487967 DOI: 10.1080\/1744666X.2021.1971973]","DOI":"10.1080\/1744666x.2021.1971973"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Backman H, R\u00e4is\u00e4nen P, Hedman L, Stridsman C, Andersson M, Lindberg A, et al. Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016\u2014results from three population surveys. Clin Exp Allergy. 2017;47:1426\u201335. [PMID: 28608416 DOI: 10.1111\/cea.12963]","DOI":"10.1111\/cea.12963"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Akar-Ghibril N, Casale T, Custovic A, Phipatanakul W. Allergic Endotypes and Phenotypes of Asthma. J Allergy Clin Immunol Pract. 2020;8:429\u201340. [PMID: 32037107 PMCID: PMC7569362 DOI: 10.1016\/j.jaip.2019.11.008]","DOI":"10.1016\/j.jaip.2019.11.008"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Lemanske RF Jr, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 2010;125:S95\u2013102. [PMID: 20176271 PMCID: PMC2853245 DOI: 10.1016\/j.jaci.2009.10.047]","DOI":"10.1016\/j.jaci.2009.10.047"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Foer D, Beeler PE, Cui J, Karlson EW, Bates DW, Cahill KN. Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists. Am J Respir Crit Care Med. 2021;203:831\u201340. [PMID: 33052715 PMCID: PMC8017590 DOI: 10.1164\/rccm.202004-0993OC]","DOI":"10.1164\/rccm.202004-0993oc"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Holguin F, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Erzurum SC, et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol. 2011;127:1486\u201393.e2. [PMID: 21624618 PMCID: PMC3128802 DOI: 10.1016\/j.jaci.2011.03.036]","DOI":"10.1016\/j.jaci.2011.03.036"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Dixon AE, Holguin F, Sood A, Salome CM, Pratley RE, Beuther DA, et al.; American Thoracic Society Ad Hoc Subcommittee on Obesity and Lung Disease. An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc. 2010;7:325\u201335. [PMID: 20844291 DOI: 10.1513\/pats.200903-013ST]","DOI":"10.1513\/pats.200903-013st"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Rogliani P, Calzetta L, Capuani B, Facciolo F, Cazzola M, Lauro D, et al. Glucagon-Like Peptide 1 Receptor: A Novel Pharmacological Target for Treating Human Bronchial Hyperresponsiveness. Am J Respir Cell Mol Biol. 2016;55:804\u201314. [PMID: 27447052 DOI: 10.1165\/rcmb.2015-0311OC]","DOI":"10.1165\/rcmb.2015-0311oc"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med. 2005;118:205\u201311. [PMID: 15745714 DOI: 10.1016\/j.amjmed.2004.09.019]","DOI":"10.1016\/j.amjmed.2004.09.019"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Miethe S, Karsonova A, Karaulov A, Renz H. Obesity and asthma. J Allergy Clin Immunol. 2020;146:685\u201393. [PMID: 33032723 DOI: 10.1016\/j.jaci.2020.08.011]","DOI":"10.1016\/j.jaci.2020.08.011"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Han W, Li J, Tang H, Sun L. Treatment of obese asthma in a mouse model by simvastatin is associated with improving dyslipidemia and decreasing leptin level. Biochem Biophys Res Commun. 2017;484:396\u2013402. [PMID: 28131832 DOI: 10.1016\/j.bbrc.2017.01.135]","DOI":"10.1016\/j.bbrc.2017.01.135"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Wu TD, Keet CA, Fawzy A, Segal JB, Brigham EP, McCormack MC. Association of Metformin Initiation and Risk of Asthma Exacerbation. A Claims-based Cohort Study. Ann Am Thorac Soc. 2019;16:1527\u201333. [PMID: 31415212 PMCID: PMC6956833 DOI: 10.1513\/AnnalsATS.201812-897OC]","DOI":"10.1513\/annalsats.201812-897oc"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Li CY, Erickson SR, Wu CH. Metformin use and asthma outcomes among patients with concurrent asthma and diabetes. Respirology. 2016;21:1210\u20138. [PMID: 27245632 DOI: 10.1111\/resp.12818]","DOI":"10.1111\/resp.12818"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Ye\u011fit OO, Sar\u0131beyliler G, Karada\u011f P, Demir S, G\u00fcl N, \u00dcnal D, et al. The first successful desensitization protocol in exenatide allergy: a case report. Allergy Asthma Clin Immunol. 2023;19:2. [PMID: 36639791 PMCID: PMC9838064 DOI: 10.1186\/s13223-023-00761-y]","DOI":"10.1186\/s13223-023-00761-y"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Kim YK, Kim OY, Song J. Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function. Front Pharmacol. 2020;11:1270. [PMID: 32922295 PMCID: PMC7456867 DOI: 10.3389\/fphar.2020.01270]","DOI":"10.3389\/fphar.2020.01270"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Detka J, G\u0142ombik K. Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression. Pharmacol Rep. 2021;73:1020\u201332. [PMID: 34003475 PMCID: PMC8413152 DOI: 10.1007\/s43440-021-00274-8]","DOI":"10.1007\/s43440-021-00274-8"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, et al. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses. Mol Neurobiol. 2018;55:3007\u201320. [PMID: 28456941 DOI: 10.1007\/s12035-017-0550-2]","DOI":"10.1007\/s12035-017-0550-2"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Dill-McFarland KA, Altman MC, Esnault S, Jarjour NN, Busse WW, Rosenkranz MA. Molecular pathways underlying lung-brain axis signaling in asthma: Relevance for psychopathology and neuroinflammation. J Allergy Clin Immunol. 2024;153:111\u201321. [PMID: 37730134 PMCID: PMC10841090 DOI: 10.1016\/j.jaci.2023.07.025]","DOI":"10.1016\/j.jaci.2023.07.025"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Liu G, Zhu R, Li B. TNF-\u03b1 and IL-8 of the patients with allergic asthma. Curr Med Sci. 2005;25:274\u20135. [PMID: 16201269 DOI: 10.1007\/BF02828140]","DOI":"10.1007\/BF02828140"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Bradding P. Asthma: eosinophil disease, mast cell disease, or both? Allergy Asthma Clin Immunol. 2008;4:84\u201390. [PMID: 20525129 PMCID: PMC2868886 DOI: 10.1186\/1710-1492-4-2-84]","DOI":"10.1186\/1710-1492-4-2-84"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"de Vries HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol. 1996;64:37\u201343. [PMID: 8598388 DOI: 10.1016\/0165-5728(95)00148-4]","DOI":"10.1016\/0165-5728(95)00148-4"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Zhang X, Dong H, Li N, Zhang S, Sun J, Zhang S, et al. Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis. J Neuroinflammation. 2016;13:127. [PMID: 27245661 PMCID: PMC4888609 DOI: 10.1186\/s12974-016-0592-9]","DOI":"10.1186\/s12974-016-0592-9"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Lambrecht BN, Hammad H, Fahy JV. The Cytokines of Asthma. Immunity. 2019;50:975\u201391. [PMID: 30995510 DOI: 10.1016\/j.immuni.2019.03.018]","DOI":"10.1016\/j.immuni.2019.03.018"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Boahen A, Hu D, Adams MJ, Nicholls PK, Greene WK, Ma B. Bidirectional crosstalk between the peripheral nervous system and lymphoid tissues\/organs. Front Immunol. 2023;14:1254054. [PMID: 37767094 PMCID: PMC10520967 DOI: 10.3389\/fimmu.2023.1254054]","DOI":"10.3389\/fimmu.2023.1254054"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Agabiti-Rosei E. Antiadrenergic Agents. In: Huhtaniemi I, Martini L, editors. Encyclopedia of Endocrine Diseases (Second Edition). Oxford: Academic Press; 2019. pp. 443\u20138. [DOI: 10.1016\/B978-0-12-801238-3.95890-2]","DOI":"10.1016\/b978-0-12-801238-3.95890-2"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Scott GD, Fryer AD. Role of parasympathetic nerves and muscarinic receptors in allergy and asthma. Chem Immunol Allergy. 2012;98:48\u201369. [PMID: 22767057 PMCID: PMC4039300 DOI: 10.1159\/000336498]","DOI":"10.1159\/000336498"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Buels KS, Fryer AD. Muscarinic Receptor Antagonists: Effects on Pulmonary Function. In: Fryer AD, Christopoulos A, Nathanson NM, editors. Muscarinic Receptors. Berlin, Heidelberg: Springer Berlin Heidelberg; 2012. pp. 317\u201341. [PMID: 22222705 PMCID: PMC4104281 DOI: 10.1007\/978-3-642-23274-9_14]","DOI":"10.1007\/978-3-642-23274-9_14"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for \u2018depression due to a general medical condition\u2019, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol. 2002;5:389\u201399. [PMID: 12466037 DOI: 10.1017\/S1461145702003152]","DOI":"10.1017\/s1461145702003152"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Kim JH. Serum vascular endothelial growth factor as a marker of asthma exacerbation. Korean J Intern Med. 2017;32:258\u201360. [PMID: 28264541 PMCID: PMC5339477 DOI: 10.3904\/kjim.2017.066]","DOI":"10.3904\/kjim.2017.066"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Gomu\u0142ka K, Liebhart J, M\u0119drala W. Vascular Endothelial Growth Factor as a Putative Biomarker of Depression in Asthmatics with Reversible Airway Narrowing. J Clin Med. 2021;10:5301. [PMID: 34830591 PMCID: PMC8622768 DOI: 10.3390\/jcm10225301]","DOI":"10.3390\/jcm10225301"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Wang Y, Mou YK, Wang HR, Song XY, Wei SZ, Ren C, et al. Brain response in asthma: the role of \u201clung-brain\u201d axis mediated by neuroimmune crosstalk. Front Immunol. 2023;14:1240248. [PMID: 37691955 PMCID: PMC10484342 DOI: 10.3389\/fimmu.2023.1240248]","DOI":"10.3389\/fimmu.2023.1240248"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Stubbs MA, Clark VL, Gibson PG, Yorke J, McDonald VM. Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma. Respir Res. 2022;23:341. [PMID: 36510255 PMCID: PMC9743554 DOI: 10.1186\/s12931-022-02266-5]","DOI":"10.1186\/s12931-022-02266-5"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Kopp KO, Glotfelty EJ, Li Y, Greig NH. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Pharmacol Res. 2022;186:106550. [PMID: 36372278 PMCID: PMC9712272 DOI: 10.1016\/j.phrs.2022.106550]","DOI":"10.1016\/j.phrs.2022.106550"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Rosenkranz MA, Dean DC 3rd, Bendlin BB, Jarjour NN, Esnault S, Zetterberg H, et al. Neuroimaging and biomarker evidence of neurodegeneration in asthma. J Allergy Clin Immunol. 2022;149:589\u201398.e6. [PMID: 34536414 PMCID: PMC8821112 DOI: 10.1016\/j.jaci.2021.09.010]","DOI":"10.1016\/j.jaci.2021.09.010"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Nair AK, Van Hulle CA, Bendlin BB, Zetterberg H, Blennow K, Wild N, et al. Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline. Alzheimers Dement (N Y). 2022;8:e12315. [PMID: 35846157 PMCID: PMC9270636 DOI: 10.1002\/trc2.12315]","DOI":"10.1002\/trc2.12315"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Tao Q, Ang TFA, DeCarli C, Auerbach SH, Devine S, Stein TD, et al. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers. JAMA Netw Open. 2018;1:e183597. [PMID: 30646251 PMCID: PMC6324596 DOI: 10.1001\/jamanetworkopen.2018.3597]","DOI":"10.1001\/jamanetworkopen.2018.3597"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Peng YH, Wu BR, Su CH, Liao WC, Muo CH, Hsia TC, et al. Adult asthma increases dementia risk: a nationwide cohort study. J Epidemiol Community Health. 2015;69:123\u20138. [PMID: 25271249 DOI: 10.1136\/jech-2014-204445]","DOI":"10.1136\/jech-2014-204445"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Chen MH, Li CT, Tsai CF, Lin WC, Chang WH, Chen TJ, et al. Risk of dementia among patients with asthma: a nationwide longitudinal study. J Am Med Dir Assoc. 2014;15:763\u20137. [PMID: 25037169 DOI: 10.1016\/j.jamda.2014.06.003]","DOI":"10.1530\/ey.16.12.2"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, et al. Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases. J Allergy Clin Immunol. 2024;153:879\u201393. [PMID: 37634890 PMCID: PMC11215634 DOI: 10.1016\/j.jaci.2023.08.017]","DOI":"10.1016\/j.jaci.2023.08.017"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Lutsey PL, Chen N, Mirabelli MC, Lakshminarayan K, Knopman DS, Vossel KA, et al. Impaired Lung Function, Lung Disease, and Risk of Incident Dementia. Am J Respir Crit Care Med. 2019;199:1385\u201396. [PMID: 30433810 PMCID: PMC6543713 DOI: 10.1164\/rccm.201807-1220OC]","DOI":"10.1164\/rccm.201807-1220oc"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Xia MX, Ding X, Qi J, Gu J, Hu G, Sun XL. Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain. J Neuroimmunol. 2014;273:53\u20137. [PMID: 24993070 DOI: 10.1016\/j.jneuroim.2014.06.005]","DOI":"10.1016\/j.jneuroim.2014.06.005"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Lin MH, Cheng PC, Hsiao PJ, Chen SC, Hung CH, Kuo CH, et al. The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4. Int Immunopharmacol. 2023;115:109653. [PMID: 36587502 DOI: 10.1016\/j.intimp.2022.109653]","DOI":"10.1016\/j.intimp.2022.109653"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320:C375\u201391. [PMID: 33356944 PMCID: PMC8294624 DOI: 10.1152\/ajpcell.00379.2020]","DOI":"10.1152\/ajpcell.00379.2020"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Miller AA, Spencer SJ. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun. 2014;42:10\u201321. [PMID: 24727365 DOI: 10.1016\/j.bbi.2014.04.001]","DOI":"10.1016\/j.bbi.2014.04.001"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005;146:4192\u20139. [PMID: 16002529 DOI: 10.1210\/en.2004-1520]","DOI":"10.1210\/en.2004-1520"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Timper K, Del R\u00edo-Mart\u00edn A, Cremer AL, Bremser S, Alber J, Giavalisco P, et al. GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function. Cell Metab. 2020;31:1189\u2013205.e13. [PMID: 32433922 PMCID: PMC7272126 DOI: 10.1016\/j.cmet.2020.05.001]","DOI":"10.1016\/j.cmet.2020.05.001"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Park JS, Kam TI, Lee S, Park H, Oh Y, Kwon SH, et al. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2021;9:78. [PMID: 33902708 PMCID: PMC8074239 DOI: 10.1186\/s40478-021-01180-z]","DOI":"10.1186\/s40478-021-01180-z"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Gonzalez Alam TRJ, Cruz Arias J, Jefferies E, Smallwood J, Leemans A, Marino Davolos J. Ventral and dorsal aspects of the inferior frontal-occipital fasciculus support verbal semantic access and visually-guided behavioural control. Brain Struct Funct. 2024;229:207\u201321. [PMID: 38070006 PMCID: PMC10827863 DOI: 10.1007\/s00429-023-02729-5]","DOI":"10.21203\/rs.3.rs-1971685\/v1"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Janelle F, Iorio-Morin C, D\u2019amour S, Fortin D. Superior Longitudinal Fasciculus: A Review of the Anatomical Descriptions With Functional Correlates. Front Neurol. 2022;13:794618. [PMID: 35572948 PMCID: PMC9093186 DOI: 10.3389\/fneur.2022.794618]","DOI":"10.3389\/fneur.2022.794618"},{"key":"ref52","unstructured":"Natali AL, Reddy V, Bordoni B. Neuroanatomy, Corticospinal Cord Tract. Treasure Island (FL): StatPearls Publishing; 2025. [PMID: 30571044]"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Burke T, Holleran L, Mothersill D, Lyons J, O\u2019Rourke N, Gleeson C, et al. Bilateral anterior corona radiata microstructure organisation relates to impaired social cognition in schizophrenia. Schizophr Res. 2023;262:87\u201394. [PMID: 37931564 DOI: 10.1016\/j.schres.2023.10.035]","DOI":"10.1016\/j.schres.2023.10.035"},{"key":"ref54","unstructured":"Emos MC, Khan Suheb MZ, Agarwal S. Neuroanatomy, Internal Capsule. Treasure Island (FL): StatPearls Publishing; 2025. [PMID: 31194338]"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Tu XK, Chen Q, Chen S, Huang B, Ren BG, Shi SS. GLP-1R Agonist Liraglutide Attenuates Inflammatory Reaction and Neuronal Apoptosis and Reduces Early Brain Injury After Subarachnoid Hemorrhage in Rats. Inflammation. 2021;44:397\u2013406. [PMID: 32951103 DOI: 10.1007\/s10753-020-01344-4]","DOI":"10.1007\/s10753-020-01344-4"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, et al. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer\u2019s Disease. J Alzheimers Dis. 2015;46:877\u201388. [PMID: 25869785 PMCID: PMC4878312 DOI: 10.3233\/JAD-143090]","DOI":"10.3233\/jad-143090"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Wu AY, Cahill KN, Toki S, Peebles RS Jr. Evaluating the glucagon-like peptide-1 receptor in managing asthma. Curr Opin Allergy Clin Immunol. 2022;22:36\u201341. [PMID: 34772827 PMCID: PMC8842827 DOI: 10.1097\/ACI.0000000000000797]","DOI":"10.1097\/aci.0000000000000797"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Grootendorst DC, Rabe KF. Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1:77\u201387. [PMID: 16113417 DOI: 10.1513\/pats.2306025]","DOI":"10.1513\/pats.2306025"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Chwalba A, Machura E, Ziora K, Ziora D. The role of adipokines in the pathogenesis and course of selected respiratory diseases. Endokrynol Pol. 2019;70:504\u201310. [PMID: 31891413 DOI: 10.5603\/EP.a2019.0051]","DOI":"10.5603\/ep.a2019.0051"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Ciprandi G, Caimmi D, Raschetti R, Miraglia Del Giudice M, Salpietro C, Caimmi S, et al. Adipokines and their role in allergies. Int J Immunopathol Pharmacol. 2011;24:13\u20136. [PMID: 22032780 DOI: 10.1177\/03946320110240S403]","DOI":"10.1177\/03946320110240s403"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Liu J, Divoux A, Sun J, Zhang J, Cl\u00e9ment K, Glickman JN, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 2009;15:940\u20135. [PMID: 19633655 PMCID: PMC2736875 DOI: 10.1038\/nm.1994]","DOI":"10.1038\/nm.1994"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Wang Y, Hu C. Leptin and Asthma: What Are the Interactive Correlations? Biomolecules. 2022;12:1780. [PMID: 36551211 PMCID: PMC9775505 DOI: 10.3390\/biom12121780]","DOI":"10.3390\/biom12121780"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Foer D, Beeler P, Cui J, Boyce J, Karlson E, Bates D, et al. Glucagon-like peptide-1 receptor agonists decrease systemic Th2 inflammation in asthmatics. J Allergy Clin Immunol. 2020;145:AB241. [DOI: 10.1016\/j.jaci.2019.12.140]","DOI":"10.1016\/j.jaci.2019.12.140"}],"container-title":["Exploration of Asthma &amp; Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.explorationpub.com\/Journals\/eaa\/Article\/100967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T05:16:39Z","timestamp":1737004599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.explorationpub.com\/Journals\/eaa\/Article\/100967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":64,"URL":"https:\/\/doi.org\/10.37349\/eaa.2025.100967","archive":["Portico"],"relation":{},"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"2024-10-3","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-1-16","order":2,"name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"100967"}}